tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
HBIO is currently covered by 1 analysts with an average price target of $2.45. This is a potential upside of $1.87 (322.41%) from yesterday's end of day stock price of $0.58.
Harvard Bioscience's activity chart (see below) currently has 12 price targets and 12 ratings on display. The stock rating distribution of HBIO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 264.5 days.
Highest price target for HBIO is $6, Lowest price target is $3.
Most recent stock forecast was given by BRUCE JACKSON from BENCHMARK on 22-Jun-2023. First documented stock forecast 24-Jan-2018.
Currently out of the existing stock ratings of HBIO, 3 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$7
$5.65 (418.52%)
$7
2 years 6 months 29 days ago
(22-Jun-2023)
1/4 (25%)
$0.93 (15.32%)
20
Buy
$5
$3.65 (270.37%)
$7
3 years 2 months 11 days ago
(09-Nov-2022)
3/6 (50%)
$2.81 (128.31%)
509
What is HBIO (Harvard Bioscience) average time for price targets to be met?
Which analyst has the current highest performing score on HBIO (Harvard Bioscience) with a proven track record?
Which analyst has the current lower performing score on HBIO (Harvard Bioscience) with a proven track record?
Which analyst has the most public recommendations on HBIO (Harvard Bioscience)?
Which analyst is the currently most bullish on HBIO (Harvard Bioscience)?
Which analyst is the currently most reserved on HBIO (Harvard Bioscience)?
